Researchers at the University of Michigan examined a data set of national insurance claims of patients who underwent curative-intent surgery from 2010-2014. Up to 10% of this population are using opioids daily, and they're using them long after their surgical oncologist would expect them to. For example, one year after surgery, 10% of patients were filling prescriptions equivalent to six tablets per day of 5 mg hydrocodone, similar levels to those of chronic opioid users. In comparison, similar studies of non-cancer surgical patients showed 6% of patients continued to fill prescriptions in the same time frame. Patients who also received chemotherapy had an even higher risk of persistent opioid use, with 15 -21% continuing to use opioids past the recommended guidelines.
How surgical oncologists can help
The authors acknowledged that emotional trauma around a cancer diagnosis, pain from the surgical procedure, and coordinating pain management across a large care team are factors that may make a patient more vulnerable to opioid misuse. The research team at Michigan focused on what practice changes to should be made in order to reduce misuse in the future.
In addition to prescribing fewer opioids, the research team emphasized the importance of pain management education that highlights the risk of addiction. They are currently conducting follow-up research to determine how much pain medication patients actually use post-surgery, and intend to use those benchmarks to advise oncologists on how to prescribe lower amounts. The research team also emphasized the importance of pain management education that focuses on the risk of addiction.
Learn the latest clinical innovations in oncology today
Join us for a webconference on June 21 to hear technology overviews and best practices for ensuring high-quality surgical and interventional oncology care.